STERIALS

A biopharmaceutical company that develops and commercializes novel antibody drugs for cancer treatment. It has commercialized a drug for the treatment of recurrent or refractory high-risk bone and bone marrow neuroblastoma for patients who have shown partial or minor responses or stable disease to previous treatments, and is developing drugs for recurrent osteosarcoma, central nervous system tumors, and other indications. Based in Delaware.